<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mechanical circulatory support is successfully applied to patients with low cardiac output </plain></SENT>
<SENT sid="1" pm="."><plain>The MEDOS-System provides pulsatile ventricular assistance for patients of <z:hpo ids='HP_0000001'>all</z:hpo> age groups, including neonates </plain></SENT>
<SENT sid="2" pm="."><plain>We report our experience with seven consecutive pediatric patients with the MEDOS-VAD </plain></SENT>
<SENT sid="3" pm="."><plain>The indication was bridge to transplantation in <z:hpo ids='HP_0000001'>all</z:hpo> patients </plain></SENT>
<SENT sid="4" pm="."><plain>Mean age was 7.3 +/- 6.5 years (range 0.75-16.9 years) and mean weight was 26.3 +/- 21.7 kg (range 5.9-60 kg) </plain></SENT>
<SENT sid="5" pm="."><plain>Perioperative survival was 100%; complications occurred in six patients (86%; two <z:e sem="disease" ids="C0007780" disease_type="Disease or Syndrome" abbrv="">cerebral embolism</z:e>/<z:mp ids='MP_0001914'>bleeding</z:mp>, two rethoracotomy, two exchange of pump chamber due to <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation after 4 and 9 days) </plain></SENT>
<SENT sid="6" pm="."><plain>Mean duration of support was 20.4 +/- 10.8 days (range 6-38 days) </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="0" ids="16990">Bilirubin</z:chebi> decreased from 3.5 +/- 2.6 mg/d to 2.1 +/- 1.2 mg/d </plain></SENT>
<SENT sid="8" pm="."><plain>Hospital mortality was three of seven patients who did not receive an organ offer in time </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients who underwent subsequent heart transplantation (four of seven patients; 57%) were discharged from the hospital </plain></SENT>
<SENT sid="10" pm="."><plain>Mechanical circulatory support with the MEDOS-System can be performed successfully in pediatric patients of any age </plain></SENT>
<SENT sid="11" pm="."><plain>Secondary organ functions improve under this pulsatile circulatory assistance </plain></SENT>
<SENT sid="12" pm="."><plain><z:mp ids='MP_0001914'>Hemorrhage</z:mp> and <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> are the most frequent complications </plain></SENT>
</text></document>